time-dependent manner in ADR clones of OS and EFTs, as indicated by reduction in the intensities of proenzymes of caspase-9 and caspase-3, and increase in the cleaved products of caspase-8 (Fig. 3c). Co-treatment with a broad-spectrum caspase inhibitor (Z-VAD-FMK) or a caspase-3 specific inhibitor (Z-DEVD-FMK) significantly reduced the efficacy of flavopiridol on the induction of the cell death in ADR cells, but a caspase-8 specific inhibitor (Z-IETD-FMK) could not inhibit the cell death (Fig. 3b). As shown in Figure 3c, 75 μM Z-VAD-FMK and 50 μM Z-DEVD-